Showing results (291-300 of 361) with videos related to
Sort By:
Pageof 37
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.Journal for Immunotherapy of Cancer|September 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaTim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.Transplantation|March 20, 2009
One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defectsJochen Meyburg, Anibh M Das, Friederike Hoerster, et al.Hepatology (Baltimore, Md.)|August 13, 2011
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entrySandra Ciesek, Thomas von Hahn, Che C Colpitts, et al.Journal of Gastrointestinal Oncology|July 11, 2024
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H Victory, Emily C Smith, Carrie E Ryan, et al.Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.Pageof 37